Alteration in insulin action: role of IRS-1 serine phosphorylation in the retroregulation of insulin signalling.

[1]  Y. Le Marchand-Brustel,et al.  Positive and negative regulation of glucose uptake by hyperosmotic stress. , 2003, Diabetes & metabolism.

[2]  K. Petersen,et al.  Cellular mechanism of insulin resistance: potential links with inflammation , 2003, International Journal of Obesity.

[3]  J. Tanti,et al.  MAP kinases and mTOR mediate insulin-induced phosphorylation of Insulin Receptor Substrate-1 on serine residues 307, 612 and 632 , 2003, Diabetologia.

[4]  Y. Satoh,et al.  JNK: a new therapeutic target for diabetes. , 2003, Current opinion in pharmacology.

[5]  Y. Le Marchand-Brustel,et al.  Hyperosmotic Stress Inhibits Insulin Receptor Substrate-1 Function by Distinct Mechanisms in 3T3-L1 Adipocytes* , 2003, Journal of Biological Chemistry.

[6]  J. Whitehead,et al.  IRS‐1 Regulation in Health and Disease , 2003, IUBMB life.

[7]  Y. Le Marchand-Brustel,et al.  Reduced activation of phosphatidylinositol-3 kinase and increased serine 636 phosphorylation of insulin receptor substrate-1 in primary culture of skeletal muscle cells from patients with type 2 diabetes. , 2003, Diabetes.

[8]  Hiroshi Sakaue,et al.  Modulation of Insulin-stimulated Degradation of Human Insulin Receptor Substrate-1 by Serine 312 Phosphorylation* , 2003, The Journal of Biological Chemistry.

[9]  Richard J Sciotti,et al.  Enhanced basal activation of mitogen-activated protein kinases in adipocytes from type 2 diabetes: potential role of p38 in the downregulation of GLUT4 expression. , 2003, Diabetes.

[10]  M. White,et al.  c-Jun N-terminal Kinase (JNK) Mediates Feedback Inhibition of the Insulin Signaling Cascade* , 2003, The Journal of Biological Chemistry.

[11]  G. Shulman,et al.  Mechanism by Which Fatty Acids Inhibit Insulin Activation of Insulin Receptor Substrate-1 (IRS-1)-associated Phosphatidylinositol 3-Kinase Activity in Muscle* , 2002, The Journal of Biological Chemistry.

[12]  Jianping Ye,et al.  Serine Phosphorylation of Insulin Receptor Substrate 1 by Inhibitor κB Kinase Complex* 210 , 2002, The Journal of Biological Chemistry.

[13]  Michael Karin,et al.  A central role for JNK in obesity and insulin resistance , 2002, Nature.

[14]  M. White,et al.  IRS proteins and the common path to diabetes. , 2002, American journal of physiology. Endocrinology and metabolism.

[15]  K. Petersen,et al.  Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. , 2002, The Journal of clinical investigation.

[16]  M. White,et al.  Phosphorylation of Ser307 in Insulin Receptor Substrate-1 Blocks Interactions with the Insulin Receptor and Inhibits Insulin Action* , 2002, The Journal of Biological Chemistry.

[17]  C. Kahn,et al.  Insulin signalling and the regulation of glucose and lipid metabolism , 2001, Nature.

[18]  Y. Zick.  Research updateInsulin resistance: a phosphorylation-based uncoupling of insulin signaling , 2001 .

[19]  Y. Zick.  Insulin resistance: a phosphorylation-based uncoupling of insulin signaling. , 2001, Trends in cell biology.

[20]  G. Sesti,et al.  Defects of the insulin receptor substrate (IRS) system in human metabolic disorders , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  T. Haruta,et al.  Mammalian Target of Rapamycin Pathway Regulates Insulin Signaling via Subcellular Redistribution of Insulin Receptor Substrate 1 and Integrates Nutritional Signals and Metabolic Signals of Insulin , 2001, Molecular and Cellular Biology.

[22]  G. Shulman,et al.  Prevention of fat-induced insulin resistance by salicylate. , 2001, The Journal of clinical investigation.

[23]  L. Mayo,et al.  A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Chen,et al.  Protein Kinase C-ζ Phosphorylates Insulin Receptor Substrate-1 and Impairs Its Ability to Activate Phosphatidylinositol 3-Kinase in Response to Insulin* , 2001, The Journal of Biological Chemistry.

[25]  G. Shulman,et al.  Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. , 2001, The Journal of clinical investigation.

[26]  Roger Davis,et al.  The c-Jun NH2-terminal Kinase Promotes Insulin Resistance during Association with Insulin Receptor Substrate-1 and Phosphorylation of Ser307 * , 2000, The Journal of Biological Chemistry.

[27]  G. Shulman,et al.  On Diabetes: Insulin Resistance Cellular Mechanisms of Insulin Resistance , 2022 .

[28]  D. Leroith,et al.  Phosphorylation of Insulin Receptor Substrate-1 (IRS-1) by Protein Kinase B Positively Regulates IRS-1 Function* , 1999, The Journal of Biological Chemistry.

[29]  P. Scifo,et al.  Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. , 1999, Diabetes.

[30]  Z Trajanoski,et al.  Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. , 1999, The New England journal of medicine.

[31]  G. Hotamisligil.  The role of TNFα and TNF receptors in obesity and insulin resistance , 1999 .

[32]  G. Shulman,et al.  Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. , 1999, Diabetes.

[33]  D L Rothman,et al.  Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. , 1999, The Journal of clinical investigation.

[34]  L. DiPietro,et al.  Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study , 1999, Diabetologia.

[35]  P. J. Randle,et al.  Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. , 1998, Diabetes/metabolism reviews.

[36]  D. Leroith,et al.  A Molecular Basis for Insulin Resistance , 1997, The Journal of Biological Chemistry.

[37]  E. Van Obberghen,et al.  Cross-talk between the Platelet-derived Growth Factor and the Insulin Signaling Pathways in 3T3-L1 Adipocytes* , 1997, The Journal of Biological Chemistry.

[38]  G. Shulman,et al.  Metabolic Defects in Lean Nondiabetic Offspring of NIDDM Parents: A Cross-Sectional Study , 1997, Diabetes.

[39]  K. Petersen,et al.  Mechanism of free fatty acid-induced insulin resistance in humans. , 1996, The Journal of clinical investigation.

[40]  E. Van Obberghen,et al.  Phosphorylation of Insulin Receptor Substrate-1 on Multiple Serine Residues, 612, 632, 662, and 731, Modulates Insulin Action (*) , 1996, The Journal of Biological Chemistry.

[41]  E. Van Obberghen,et al.  Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling. , 1994, The Journal of biological chemistry.

[42]  E. Van Obberghen,et al.  Effects of okadaic acid, an inhibitor of protein phosphatases-1 and -2A, on glucose transport and metabolism in skeletal muscle. , 1991, The Journal of biological chemistry.